Upgrade to SI Premium - Free Trial

Roivant Sciences (ROIV) PT Raised to $55 at TD Cowen

September 9, 2026 5:38 AM
TD Cowen analyst Yaron Werber raised the price target on Roivant Sciences (NASDAQ: ROIV) to $55.00 (from $50.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change